Abstract:Chronic inflammation is considered as a critical cause of a host of disorders, such as cancer, rheumatoid arthritis, atherosclerosis, and neurodegenerative diseases, although the exact mechanism is yet to be explored. Imaging tools that can specifically target inflammation are therefore important to help reveal the role of inflammation in disease progression, and allows for developing new therapeutic strategies to ultimately improve patient care. The purpose of this study was to develop a new in vivo inflammation imaging approach by targeting the cannabinoid receptor type 2 (CB2R), an emerging inflammation biomarker, using a unique near infrared (NIR) fluorescent probe. Herein, we report the first in vivo CB2R-targeted NIR inflammation imaging study using a synthetic fluorescent probe developed in our laboratory, NIR760-mbc94. In vitro binding assay and fluorescence microscopy study indicate NIR760-mbc94 specifically binds towards CB2R in mouse RAW264.7 macrophage cells. Furthermore, in vivo imaging was performed using a Complete Freund's Adjuvant (CFA)-induced inflammation mouse model. NIR760-mbc94 successfully identified inflamed tissues and the probe uptake was blocked by a CB2R ligand, SR144528. Additionally, immunofluorescence staining in cryosectioned tissues validated the NIR760-mbc94 uptake in inflamed tissues. In conclusion, this study reports the first in vivo CB2R-targeted inflammation imaging using an NIR fluorescent probe. Specific targeting of NIR760-mbc94 has been demonstrated in macrophage cells, as well as a CFA-induced inflammation mouse model. The combined evidence indicates that NIR760-mbc94 is a promising inflammation imaging probe. Moreover, in vivo CB2R-targeted fluorescence imaging may have potential in the study of inflammation-related diseases.

In Vivo High-resolution Ratiometric Fluorescence Imaging of Inflammation Using NIR-II Nanoprobes with 1550 Nm Emission

Near-infrared-IIb Probe Affords Ultrahigh Contrast Inflammation Imaging.

NIR‐II Chemiluminescence Molecular Sensor for in Vivo High‐Contrast Inflammation Imaging

Engineering of Reversible NIR‐II Redox‐Responsive Fluorescent Probes for Imaging of Inflammation in Vivo

Advanced NIR ratiometric probes for intravital biomedical imaging

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging.

Single Wavelength Laser Excitation Ratiometric NIR-II Fluorescent Probe for Molecule Imaging in Vivo.

Er3+ Sensitized 1530 Nm to 1180 Nm Second Near‐Infrared Window Upconversion Nanocrystals for in Vivo Biosensing

Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging

NIR-II Cell Endocytosis-Activated Fluorescent Probes for in Vivo High-Contrast Bioimaging Diagnostics.

NIR-II Self-Luminous Molecular Probe for In Vivo Inflammation Tracking and Cancer PDT Effect Self-Evaluating

Dye-Triplet-Sensitized Downshifting Nanoprobes with Ratiometric Dual-NIR-IIb Emission for Accurate in Vivo Detection.

Molecular-Based FRET Nanosensor with Dynamic Ratiometric NIR-IIb Fluorescence for Real-Time in Vivo Imaging and Sensing

In vivo NIR-II fluorescence imaging for biology and medicine

Second Near-Infrared Window Fluorescence Nanoprobes for Deep-Tissue in Vivo Multiplexed Bioimaging.

Rational Design of NIR-II Ratiometric Fluorescence Probes for Accurate Bioimaging and Biosensing in Vivo

Engineering of Cyanine-Based Nanoplatform with Tunable Response Toward Reactive Species for Ratiometric NIR-II Fluorescent Imaging in Mice.

Near-infrared fluorescent probes for non-invasive, real-time, and dual-color in vivo NIR-II imaging

In Vivo Inflammation Imaging Using A Cb2r-Targeted Near Infrared Fluorescent Probe

Fluorescence Imaging In Vivo at Wavelengths beyond 1500 nm

Activatable NIR-II Organic Fluorescent Probes for Bioimaging